Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.

Jodi A KagiharaElena ShagisultanovaAnosheh AfghahiJennifer R Diamond

Published in: Current breast cancer reports (2021)

Various novel targeted agents as monotherapy, dual targeted combinations, and chemotherapy combinations are currently under investigation. The results are promising and may significantly improve patient outcomes in TNBC.

Keyphrases

cancer therapy
locally advanced
open label
drug delivery
squamous cell carcinoma
randomized controlled trial
clinical trial
rectal cancer